| |
Women (n = 399)
|
Men (n = 192)
|
Total (n = 593) c
|
Odds ratio (95% CI) MSFP vs. no MSFP
|
|---|
|
Heart disease
|
4 (1.0)
|
7 (3.6)
|
11 (1.9)
|
0.56 (0.15–2.14)
|
|
Treatment
|
4 (1.0)
|
5 (2.6)
|
9 (1.5)
| |
|
Limiting
|
3 (0.8)
|
0 (0.0)
|
3 (0.5)
| |
|
High BP
|
36 (9.0)
|
22 (11.5)
|
58 (9.8)
|
1.85 (1.07–3.18) **
|
|
Treatment
|
32 (8.0)
|
17 (8.9)
|
49 (8.3)
| |
|
Limiting
|
2 (0.5)
|
2 (1.0)
|
4 (0.7)
| |
|
Lung Disease
|
12 (3.0)
|
4 (2.1)
|
16 (2.7)
|
0.91 (0.33–2.5)
|
|
Treatment
|
12 (3.0)
|
3 (1.6)
|
15 (2.5)
| |
|
Limiting
|
7 (1.8)
|
2 (1.0)
|
9 (1.5)
| |
|
Diabetes
|
8 (2.0)
|
13 (6.8)
|
21 (3.5)
|
0.75 (0.29–1.88
|
|
Treatment
|
6 (1.5)
|
9 (4.7)
|
15 (2.5)
| |
|
Limiting
|
0 (0.0)
|
1 (0.5)
|
1 (0.2)
| |
|
Ulcer/stomach
|
10 (2.5)
|
7 (3.6)
|
17 (2.9)
|
2.21 (0.83–5.89) *
|
|
Treatment
|
10 (2.5)
|
5 (2.6)
|
15 (2.5)
| |
|
Limiting
|
2 (0.5)
|
1 (0.5)
|
3 (0.5)
| |
|
Kidney disease d
|
2 (0.5)
|
3 (1.6)
|
5 (0.8)
|
2.29 (0.38–13.78)
|
|
Treatment
|
1 (0.3)
|
1 (0.5)
|
2 (0.3)
| |
|
Limiting
|
0 (0.0)
|
1 (0.5)
|
1 (0.2)
| |
|
Liver disease
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
–
|
|
Treatment
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
| |
|
Limiting
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
| |
|
Anaemia/blood
|
17 (4.3)
|
2 (1.0)
|
19 (3.2)
|
1.71 (0.69–4.28)
|
|
Treatment
|
14 (3.5)
|
2 (1.0)
|
16 (2.7)
| |
|
Limiting
|
2 (0.5)
|
0 (0.0)
|
0 (0.0)
| |
|
Cancer d
|
3 (0.8)
|
2 (1.0)
|
5 (0.8)
|
2.29 (0.38–13.78)
|
|
Treatment
|
3 (0.8)
|
1 (0.5)
|
4 (0.7)
| |
|
Limiting
|
1 (0.3)
|
0 (0.0)
|
0 (0.0)
| |
|
Depression
|
50 (12.5)
|
17 (8.9)
|
67 (11.2)
|
1.54 (0.93–2.57) *
|
|
Treatment
|
41 (10.3)
|
10 (5.2)
|
51 (8.6)
| |
|
Limiting
|
25 (6.3)
|
7 (3.6)
|
22 (3.7)
| |
|
Osteoarthritis
|
30 (7.5)
|
3 (1.6)
|
33 (5.6)
|
1.88 (0.93–3.81) *
|
|
Treatment
|
14 (3.5)
|
1 (0.5)
|
15 (2.5)
| |
|
Limiting
|
19 (4.8)
|
3 (1.6)
|
22 (3.7)
| |
|
Back pain
|
114 (28.6)
|
42 (21.9)
|
156 (26.3)
|
2.04 (1.41–2.95) **
|
|
Treatment
|
34 (8.5)
|
17 (8.9)
|
51 (8.6)
| |
|
Limiting
|
43 (10.8)
|
14 (7.3)
|
57 (9.6)
| |
|
Rheumatoid arthritis d
|
5 (1.3)
|
4 (2.1)
|
9 (1.5)
|
12.49 (1.55–100.54) **
|
|
Treatment
|
5 (1.3)
|
2 (1.0)
|
7 (1.2)
| |
|
Limiting
|
1 (0.3)
|
3 (1.6)
|
4 (0.7)
| |
|
Hip pain
|
61 (15.3)
|
9 (4.70)
|
70 (11.8)
|
2.72 (1.63–4.55) **
|
|
Treatment
|
17 (4.3)
|
3 (1.6)
|
20 (3.4)
| |
|
Limiting
|
28 (7.0)
|
3 (1.6)
|
31 (5.2)
| |
|
Knee pain
|
101 (25.3)
|
36 (18.8)
|
137 (23.1)
|
1.56 (1.06–2.30) **
|
|
Treatment
|
30 (7.5)
|
9 (4.7)
|
39 (6.6)
| |
|
Limiting
|
54 (13.5)
|
19 (9.9)
|
73 (12.3)
| |
|
Other
|
76 (19.0)
|
39 (20.3)
|
115 (19.4)
|
1.50 (0.99–2.27) *
|
|
Treatment
|
38 (9.5)
|
18 (9.4)
|
56 (9.4)
| |
|
Limiting
|
15 (3.8)
|
15 (7.8)
|
30 (5.1)
| |
|
SCQ total, median (IQR)
|
1 (0–3)
|
1 (0–3)
|
1 (0–3)
|
–
|
|
≥ 1 Medical condition
|
226 (56.6)
|
101 (52.6)
|
327 (55.1)
|
1.94 (1.38–2.72) **
|
|
≥ 2 Medical conditions (multi-morbidity)
|
110 (27.6)
|
50 (26.0)
|
160 (26.9)
|
2.04 (1.42–2.95) **
|
|
Overweight a
|
193 (52.7)
|
122 (63.5)
|
316 (56.0)
|
2.01 (1.41–2.88) **
|
|
Low physical activity b
|
45 (11.3)
|
18 (9.4)
|
64 (12.5)
|
0.93 (0.54–1.58)
|
|
Current smoker
|
19 (4.8)
|
13 (6.8)
|
32 (5.4)
|
0.90 (0.43–1.88)
|
- an = 47 values missing
- bn = 82 values missing
- cincludes 2 cases who preferred not to disclose gender
- dFisher’s exact test conducted where cell frequencies < 5
- *significant at p < 0.2
- **significant at p < 0.05
